Dexcom G6 Intervention Study

NACompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

June 26, 2019

Primary Completion Date

February 27, 2021

Study Completion Date

February 27, 2021

Conditions
Diabetes Mellitus
Interventions
DEVICE

Dexcom G6 CGM - Continues Glucose Monitoring sensor system

A blinded factory-calibrated continues glucose monitoring sensor system Dexcom G6 will be placed shortly after admission. Two CGM devices will be inserted in all patients - one in the abdomen and one in the arm to also assess differences in blood glucose readings between upper extremity and abdominal insertion sites. Information on CGM readings will be collected daily during the hospital stay up to 10 days using the Dexcom Studio software to download the Dexcom receiver data.

DIAGNOSTIC_TEST

POC BG - Point-of-Care Blood Glucose monitoring

Standard of care - bedside point-of-care (POC) capillary blood glucose (BG) monitoring will be done before meals and bedtime daily during the hospital stay up to 10 days.

Trial Locations (3)

21201

Univeristy of Maryland, Baltimore

30322

Emory University Hospital, Atlanta

Grady Health System, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT03877068 - Dexcom G6 Intervention Study | Biotech Hunter | Biotech Hunter